| Mrs Kourtney Harrington, MD | |
|
1 Mercy Way Ste 20, Bella Vista, AR 72714-3000 | |
| (479) 802-5555 | |
| (479) 876-2829 |
| Full Name | Mrs Kourtney Harrington |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 1 Mercy Way Ste 20, Bella Vista, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962762682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 29206 (Oklahoma) | Secondary |
| 207R00000X | Internal Medicine | 51907 (Arizona) | Secondary |
| 207R00000X | Internal Medicine | E-14522 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Circle Of Life Hospice | Springdale, AR | Hospice |
| Mercy Hospital Northwest Arkansas | Rogers, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Health Northwest Arkansas Communities | 0648177873 | 265 |
News Archive
Avedro, Inc. announced today that the Company submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for its VibeX (riboflavin ophthalmic solution) /KXL System for the treatment of keratoconus and corneal ectasia following refractive surgery.
A Taiwanese research team, led by Prof. Ming-Shing Young of Department of Electrical Engineering at National Cheng Kung University (NCKU), has successfully developed a large-scale proactive cancer treatment system first-generation prototype which includes Frequency-Adjustable High Frequency Induction Heating Machine (HFIHM) and 3D Magnetically Guiding Endoscope System (3DMGES).
By voice vote, the task force called on the National Association of Insurance Commissioners to endorse legislation by Rep. Mike Rogers that would exclude fees paid to agents and brokers when calculating how much health plans are spending on administrative costs versus medical care.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
Midwest Compassion Center and Dr. Alan Shackelford join forces in the fight to treat epilepsy through the use of medical cannabis at their Will County dispensary. With growing concerns over the potentially negative side effects of pharmaceuticals and their inability to provide adequate symptom control in as many as 30% of patients with seizures, Dr. Shackelford and MCC will collaborate on research with the goal of developing new treatment options for patients dealing with a debilitating illness or condition, including seizures.
› Verified 9 days ago
| Entity Name | Mercy Health Northwest Arkansas Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265490916 PECOS PAC ID: 0648177873 Enrollment ID: O20031216000788 |
News Archive
Avedro, Inc. announced today that the Company submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for its VibeX (riboflavin ophthalmic solution) /KXL System for the treatment of keratoconus and corneal ectasia following refractive surgery.
A Taiwanese research team, led by Prof. Ming-Shing Young of Department of Electrical Engineering at National Cheng Kung University (NCKU), has successfully developed a large-scale proactive cancer treatment system first-generation prototype which includes Frequency-Adjustable High Frequency Induction Heating Machine (HFIHM) and 3D Magnetically Guiding Endoscope System (3DMGES).
By voice vote, the task force called on the National Association of Insurance Commissioners to endorse legislation by Rep. Mike Rogers that would exclude fees paid to agents and brokers when calculating how much health plans are spending on administrative costs versus medical care.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
Midwest Compassion Center and Dr. Alan Shackelford join forces in the fight to treat epilepsy through the use of medical cannabis at their Will County dispensary. With growing concerns over the potentially negative side effects of pharmaceuticals and their inability to provide adequate symptom control in as many as 30% of patients with seizures, Dr. Shackelford and MCC will collaborate on research with the goal of developing new treatment options for patients dealing with a debilitating illness or condition, including seizures.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kourtney Harrington, MD 1 Mercy Way Ste 20, Bella Vista, AR 72714-3000 Ph: (479) 802-5555 | Mrs Kourtney Harrington, MD 1 Mercy Way Ste 20, Bella Vista, AR 72714-3000 Ph: (479) 802-5555 |
News Archive
Avedro, Inc. announced today that the Company submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for its VibeX (riboflavin ophthalmic solution) /KXL System for the treatment of keratoconus and corneal ectasia following refractive surgery.
A Taiwanese research team, led by Prof. Ming-Shing Young of Department of Electrical Engineering at National Cheng Kung University (NCKU), has successfully developed a large-scale proactive cancer treatment system first-generation prototype which includes Frequency-Adjustable High Frequency Induction Heating Machine (HFIHM) and 3D Magnetically Guiding Endoscope System (3DMGES).
By voice vote, the task force called on the National Association of Insurance Commissioners to endorse legislation by Rep. Mike Rogers that would exclude fees paid to agents and brokers when calculating how much health plans are spending on administrative costs versus medical care.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
Midwest Compassion Center and Dr. Alan Shackelford join forces in the fight to treat epilepsy through the use of medical cannabis at their Will County dispensary. With growing concerns over the potentially negative side effects of pharmaceuticals and their inability to provide adequate symptom control in as many as 30% of patients with seizures, Dr. Shackelford and MCC will collaborate on research with the goal of developing new treatment options for patients dealing with a debilitating illness or condition, including seizures.
› Verified 9 days ago
David Scott Estes, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Way, Bella Vista, AR 72714 Phone: 479-802-5555 Fax: 479-876-2829 | |
Dr. Larry Don Wright, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 Forest Hills Blvd, Suite 201, Bella Vista, AR 72715 Phone: 479-876-6566 | |
Dr. Bilquis Imtiaz Khot, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1801 Forest Hills Blvd., Ste. 201, Bella Vista, AR 72715 Phone: 479-876-6566 Fax: 479-876-2933 | |
Cara L. Riley, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Way, Bella Vista, AR 72714 Phone: 479-802-5555 Fax: 479-876-2829 | |
Dr. Margaret P Ellis, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 600 Memorial Dr, Bella Vista, AR 72714 Phone: 479-855-6165 Fax: 479-855-2831 | |
Dr. Michael Dallas Sammer, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 600 Memorial Drive, Bella Vista, AR 72714 Phone: 479-855-6165 Fax: 479-855-2831 | |
Gary F Frigon, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7 Frensham Ln, Bella Vista, AR 72715 Phone: 479-381-6362 |